Franklin Genomic Advancements ETF (HELX)
Data kepemilikan belum tersedia untuk dana ini.
HELX Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Performa per 2 Okt. 2026
| Periode | Imbal hasil harga | Imbal hasil total |
|---|---|---|
| 1M | ▲ +3,11% | ▲ +3,11% |
| 3M | · | · |
| 6M | · | · |
| YTD | · | · |
| 1Y | · | · |
| 3Y | · | · |
| 5Y | · | · |
| Maks | ▲ +6,83% | ▲ +6,83% |
Total pengembalian mengasumsikan dividen diinvestasikan kembali. Pengembalian tidak dibandingkan dengan indeks. * Rasio Sharpe dihitung dengan suku bunga bebas risiko 0%.
Aliran dana (dilaporkan SEC)
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Komposisi Penuh 63 saham
| Nama | CUSIP | Nilai | % | Saldo | Kategori | Negara |
|---|---|---|---|---|---|---|
| GUARDANT HEALTH INC | 40131M109 | $2.5M | 9,09 | 16.927 | EC | US |
| NATERA INC | 632307104 | $2.1M | 7,46 | 7.679 | EC | US |
| KRYSTAL BIOTECH INC | 501147102 | $1.8M | 6,33 | 4.757 | EC | US |
| LIGAND PHARMACEUTICALS INC | 53220K504 | $1.3M | 4,62 | 4.085 | EC | US |
| ADAPTIVE BIOTECHNOLOGIES CORP | 00650F109 | $1.1M | 3,99 | 51.956 | EC | US |
| UNITED THERAPEUTICS CORP | 91307C102 | $980K | 3,51 | 1.809 | EC | US |
| BRIDGEBIO PHARMA INC | 10806X102 | $978K | 3,50 | 13.129 | EC | US |
| ELI LILLY & COMPANY | 532457108 | $825K | 2,95 | 688 | EC | US |
| TWIST BIOSCIENCE CORP | 90184D100 | $796K | 2,85 | 7.736 | EC | US |
| VERTEX PHARMACEUTICALS INC | 92532F100 | $767K | 2,75 | 1.545 | EC | US |
| ASTRAZENECA PLC | · | $754K | 2,70 | 3.979 | EC | GB |
| TRAVERE THERAPEUTICS INC | 89422G107 | $724K | 2,59 | 12.753 | EC | US |
| INSMED INC | 457669307 | $681K | 2,44 | 6.388 | EC | US |
| SAMSUNG BIOLOGICS CO LTD | · | $630K | 2,26 | 702 | EC | KR |
| CORTEVA INC | 22052L104 | $630K | 2,25 | 7.435 | EC | US |
| MEDPACE HOLDINGS INC | 58506Q109 | $600K | 2,15 | 1.133 | EC | US |
| ALNYLAM PHARMACEUTICALS INC | 02043Q107 | $547K | 1,96 | 1.816 | EC | US |
| TEMPUS AI INC | 88023B103 | $544K | 1,95 | 9.397 | EC | US |
| IONIS PHARMACEUTICALS INC | 462222100 | $534K | 1,91 | 6.739 | EC | US |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | $515K | 1,84 | 3.058 | EC | US |
| REGENERON PHARMACEUTICALS INC | 75886F107 | $502K | 1,80 | 805 | EC | US |
| VERACYTE INC | 92337F107 | $459K | 1,64 | 7.819 | EC | US |
| ARGENX SE | · | $458K | 1,64 | 494 | EC | NL |
| PTC THERAPEUTICS INC | 69366J200 | $409K | 1,46 | 5.009 | EC | US |
| BIONTECH SE | 09075V102 | $387K | 1,38 | 4.156 | EC | DE |
| STOKE THERAPEUTICS INC | 86150R107 | $371K | 1,33 | 11.349 | EC | US |
| CHARLES RIVER LABORATORIES INTERNATIONAL INC | 159864107 | $353K | 1,26 | 1.556 | EC | US |
| GRAIL INC | 384747101 | $304K | 1,09 | 4.456 | EC | US |
| ANAPTYSBIO INC | 032724106 | $290K | 1,04 | 4.290 | EC | US |
| CRISPR THERAPEUTICS AG | · | $274K | 0,98 | 5.030 | EC | CH |
| REPLIGEN CORP | 759916109 | $274K | 0,98 | 2.009 | EC | US |
| CADENCE DESIGN SYSTEMS INC | 127387108 | $272K | 0,97 | 725 | EC | US |
| BEAM THERAPEUTICS INC | 07373V105 | $260K | 0,93 | 7.577 | EC | US |
| PRAXIS PRECISION MEDICINES INC | 74006W207 | $240K | 0,86 | 718 | EC | US |
| SARTORIUS AG | · | $238K | 0,85 | 905 | EP | DE |
| AXSOME THERAPEUTICS INC | 05464T104 | $229K | 0,82 | 936 | EC | US |
| CAREDX INC | 14167L103 | $228K | 0,82 | 8.000 | EC | US |
| JAZZ PHARMACEUTICALS PLC | · | $218K | 0,78 | 905 | EC | IE |
| CATALYST PHARMACEUTICALS INC | 14888U101 | $216K | 0,77 | 6.865 | EC | US |
| THERMO FISHER SCIENTIFIC INC | 883556102 | $211K | 0,76 | 421 | EC | US |
| IQVIA HOLDINGS INC | 46266C105 | $209K | 0,75 | 1.082 | EC | US |
| HINGE HEALTH INC | 433313103 | $195K | 0,70 | 2.349 | EC | US |
| ULTRAGENYX PHARMACEUTICAL INC | 90400D108 | $171K | 0,61 | 5.131 | EC | US |
| AGILENT TECHNOLOGIES INC | 00846U101 | $162K | 0,58 | 1.223 | EC | US |
| DANAHER CORP | 235851102 | $160K | 0,57 | 842 | EC | US |
| QIAGEN NV | · | $134K | 0,48 | 3.419 | EC | NL |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | $116K | 0,42 | 1.048 | EC | US |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | $116K | 0,42 | 4.422 | EC | US |
| SAMSUNG EPIS HOLDINGS CO LTD | · | $104K | 0,37 | 376 | EC | KR |
| KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | · | $95K | 0,34 | 1.479 | EC | GB |
Dividen 4 pembayaran
| Tanggal ex-dividen | Jumlah / saham |
|---|---|
| 30 Des. 2025 | $0,1430 |
| 30 Des. 2021 | $0,0040 |
| 13 Des. 2021 | $0,1140 |
| 14 Des. 2020 | $0,0520 |
Pemilik institusional (13F) 8 pengaju
Institusi yang melaporkan kepemilikan ETF ini dalam Formulir SEC 13F triwulanan mereka. Hanya posisi long; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
| Institusi | Nilai | % dari 13F yang dilacak | Saham | Tipe | Per tanggal |
|---|---|---|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.529.544 | 40,48% | 38.272 | Saham | 30 Juni 2026 |
| CITADEL ADVISORS LLC | $1.350.820 | 35,75% | 33.800 | Saham | 30 Juni 2026 |
| LPL Financial LLC | $615.622 | 16,29% | 15.404 | Saham | 30 Juni 2026 |
| OSAIC HOLDINGS, INC. | $125.643 | 3,33% | 3.142 | Saham | 30 Juni 2026 |
| FRANKLIN RESOURCES INC | $106.907 | 2,83% | 2.675 | Saham | 30 Juni 2026 |
| HARBOUR INVESTMENTS, INC. | $50.146 | 1,33% | 1.255 | Saham | 30 Juni 2026 |
| HUNTINGTON NATIONAL BANK | $14 | 0,00% | 1 | Saham | 30 Juni 2026 |
| JPMORGAN CHASE & CO | $1 | 0,00% | 0 | Saham | 30 Juni 2026 |